HLA DR2 in narcolepsy with sleep-onset REM periods but not cataplexy. 1991

L Rosenthal, and T A Roehrs, and H Hayashi, and F J Zorick, and R M Wittig, and J Rosenthal, and T Roth
Sleep Disorders and Research Center, Henry Ford Hospital, Detroit, MI 48202.

To determine the association of HLA DR2 in patients with narcolepsy without cataplexy, a case-control study was performed. Patients receiving the diagnosis of narcolepsy without cataplexy had excessive daytime sleepiness (EDS) and polysomnographic findings consistent with narcolepsy but no clinical evidence of cataplexy. Of 28 patients identified, 12 agreed to return for HLA typing. Respondents did not differ from nonrespondents in demographic, clinical, or sleep laboratory data. The comparison group was 503 individuals, those 30 years and older, on the Michigan Kidney Transplant Registry. The odds ratio obtained from logistic regression indicated a strong association between narcolepsy without cataplexy and HLA DR2. To control for potential confounding variables, multivariate models were constructed to explore the joint effects of HLA DR2 and each one of the covariates (age, sex, and race), their possible combinations, and the effect of all three covariates. The odds ratios decreased minimally and the association between the disease and HLA DR2 remained significant.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009290 Narcolepsy A condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness (microsomnias) that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement (REM) sleep, which normally follows stage III or IV sleep. (From Neurology 1998 Feb;50(2 Suppl 1):S2-S7) Gelineau Syndrome,Narcolepsy-Cataplexy Syndrome,Paroxysmal Sleep,Gelineau's Syndrome,Narcoleptic Syndrome,Gelineau's Syndromes,Gelineaus Syndrome,Narcolepsy Cataplexy Syndrome,Narcolepsy-Cataplexy Syndromes,Narcoleptic Syndromes,Sleep, Paroxysmal,Syndrome, Gelineau,Syndrome, Gelineau's,Syndrome, Narcolepsy-Cataplexy,Syndrome, Narcoleptic,Syndromes, Gelineau's,Syndromes, Narcolepsy-Cataplexy,Syndromes, Narcoleptic
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002385 Cataplexy A condition characterized by transient weakness or paralysis of somatic musculature triggered by an emotional stimulus or physical exertion. Cataplexy is frequently associated with NARCOLEPSY. During a cataplectic attack, there is a marked reduction in muscle tone similar to the normal physiologic hypotonia that accompanies rapid eye movement sleep (SLEEP, REM). (From Adams et al., Principles of Neurology, 6th ed, p396) Henneberg Syndrome,Status Cataplexicus,Tonelessness Syndrome,Cataleptic Attacks,Attack, Cataleptic,Attacks, Cataleptic,Cataleptic Attack,Syndrome, Henneberg,Syndrome, Tonelessness,Syndromes, Tonelessness,Tonelessness Syndromes
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D005260 Female Females
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L Rosenthal, and T A Roehrs, and H Hayashi, and F J Zorick, and R M Wittig, and J Rosenthal, and T Roth
December 1990, Biological psychiatry,
L Rosenthal, and T A Roehrs, and H Hayashi, and F J Zorick, and R M Wittig, and J Rosenthal, and T Roth
February 1988, The British journal of psychiatry : the journal of mental science,
L Rosenthal, and T A Roehrs, and H Hayashi, and F J Zorick, and R M Wittig, and J Rosenthal, and T Roth
February 1988, Israel journal of medical sciences,
L Rosenthal, and T A Roehrs, and H Hayashi, and F J Zorick, and R M Wittig, and J Rosenthal, and T Roth
November 2000, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
L Rosenthal, and T A Roehrs, and H Hayashi, and F J Zorick, and R M Wittig, and J Rosenthal, and T Roth
January 2010, Neuro endocrinology letters,
L Rosenthal, and T A Roehrs, and H Hayashi, and F J Zorick, and R M Wittig, and J Rosenthal, and T Roth
August 2007, Sleep,
L Rosenthal, and T A Roehrs, and H Hayashi, and F J Zorick, and R M Wittig, and J Rosenthal, and T Roth
October 1998, Praxis,
L Rosenthal, and T A Roehrs, and H Hayashi, and F J Zorick, and R M Wittig, and J Rosenthal, and T Roth
June 2008, Sleep,
L Rosenthal, and T A Roehrs, and H Hayashi, and F J Zorick, and R M Wittig, and J Rosenthal, and T Roth
April 2016, Journal of sleep research,
L Rosenthal, and T A Roehrs, and H Hayashi, and F J Zorick, and R M Wittig, and J Rosenthal, and T Roth
September 1986, Human immunology,
Copied contents to your clipboard!